These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 44785)
1. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)]. Loch R; Schröter G Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785 [TBL] [Abstract][Full Text] [Related]
2. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)]. Schröter G; Loch R Zentralbl Bakteriol Orig A; 1979; 245(3):317-23. PubMed ID: 44786 [TBL] [Abstract][Full Text] [Related]
3. [Probability of resistance to 10 standard- and 7 recently introduced antimicrobics in multiresistant strains of Escherichia coli, Proteus mirabilis and klebsiella spec (author's transl)]. Schröter G; Hümpfner A Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):31-42. PubMed ID: 375624 [No Abstract] [Full Text] [Related]
4. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins]. Braveny I; Dickert H; Machka K Infection; 1979; 7(5):231-6. PubMed ID: 389804 [TBL] [Abstract][Full Text] [Related]
5. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)]. Schassan HH Infection; 1979; 7 Suppl 6():527-31. PubMed ID: 399243 [TBL] [Abstract][Full Text] [Related]
6. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species]. Schröter G; Schrettenbrunner A; Strenzel I Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236 [TBL] [Abstract][Full Text] [Related]
7. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)]. Thabaut A; Durosoir JL; Saliou P Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496 [TBL] [Abstract][Full Text] [Related]
8. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S Infection; 1983; 11(6):315-7. PubMed ID: 6321357 [TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)]. Shah PM; Zwischenbrugger H; Stille W MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. George WL; Lewis RP; Meyer RD Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates. Skar AG; Midtvedt T; Dahl O NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460 [TBL] [Abstract][Full Text] [Related]
12. [Multiple drug resistance in different medical institutions: frequency and resistance patterns in Escherichia coli, Proteus mirabilis and klebsiella spec (author's transl)]. Schröter G; Hümpfner A Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):43-56. PubMed ID: 375625 [No Abstract] [Full Text] [Related]
14. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines. Barry AL; Jones RN; Thornsberry C Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092 [TBL] [Abstract][Full Text] [Related]
15. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin. Brorson JE; Norrby R Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150 [No Abstract] [Full Text] [Related]
16. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model. Randolph JA; Buck RE; Price KE; Leitner F J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292 [TBL] [Abstract][Full Text] [Related]
17. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Larsson P; Lincoln K; Lind L; Sandberg T Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617 [TBL] [Abstract][Full Text] [Related]
18. [Activity of new cephalosporins against polyresistant bacterial strains]. De Toffoli A; Fantin B Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736 [TBL] [Abstract][Full Text] [Related]
19. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin]. Schassan HH; Bentfeld G Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547 [TBL] [Abstract][Full Text] [Related]
20. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Tan TY; Ng SY; Teo L; Koh Y; Teok CH J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]